Australia, Feb. 24 -- Glyphic Biotechnologies Inc., owns the trademark (2610233) for 'ProSE' till Dec. 8, 2035.
Status: registered:
Registered/protected
Classes: 1 [Assays, reagent kits, and chemical preparations for research purposes for use in the molecular analysis of proteins and protein sequencing; substrates for use in the molecular analysis of proteins in the fields of diagnostics, scientific, pharmaceutical, biochemical assays, and biomedical research], 9 [Scientific apparatus and instruments for measuring and analyzing proteins; downloadable computer software for use in analysis and interpreting of protein sequence data; computer hardware and downloadable computer software for receiving, processing, transmitting and displaying data in the fields of protein sequencing and proteomics; computer software for controlling laboratory instruments used in protein sequencing], 10 [Clinical and medical diagnostic instruments, namely, protein sequencers in the nature of medical diagnostic apparatus for testing proteins], 35 [Technology transfer services (business services) in the field of protein sequencing and proteomics platforms], 42 [Scientific research and development services, namely, protein sequencing services; scientific research in the field of molecular analysis of proteins and protein sequencing; software as a service services featuring software for use in analysis of protein sequence data; software as a service services featuring software for receiving, processing, transmitting and displaying data in the fields of protein sequencing and proteomics] and 44 [Medical testing for diagnostic or treatment purposes, namely, protein sequencing services; clinical laboratory testing services for protein biomarker identification]
Type of Mark: Word
Date of Acceptance: Dec. 15, 2025
Registration Advertised: Feb. 23
For further details contact By George Legal.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2610233.
Disclaimer: Curated by HT Syndication.
